Federal health advisers on Tuesday voted in favor of an experimental drug from InterMune Inc., despite mixed evidence of whether it provides significant benefits for patients with a rare lung disease. The Food and Drug Administration's panel of lung experts voted 9-3 to recommend approval of ...

NEW YORK (Reuters Health) - People who get enough fiber in their diets, particularly from whole grains, may have a lower risk of developing chronic lung disease than those who eat few high-fiber foods, a new study finds. The study, of more than 100,000 U.S. adults followed between 1984 and 2000, found that those with the highest fiber intake ...

NEW YORK (Reuters Health) - Middle-aged adults who were born at a relatively low weight may have more breathing difficulties than those who were bigger newborns, a new study suggests. In a study of 627 Chinese men and women in their 40s, researchers found that participants' scores on standard lung-function tests generally lined up with their birth weights. The lowest average ...

LONDON (Reuters) - Results of a trial of Pfizer's Prevnar 7 vaccine against a major cause of pneumonia and meningitis showed on Wednesday that it can prevent three out of four cases of re-infection in HIV-infected adults in Africa. British researchers who tested the shot in Malawi found it stopped 74 percent of recurrent cases of invasive pneumococcal disease (IPD ...